Al18F-N230A

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameAl18F-N230A
Drug Alias NameAl18F-N230A
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) > Peptide Radionuclide ConjugateRadiation-emitting products > Peptide Radionuclide ConjugateDiagnostic agent (In vivo) > Radionuclide Imaging agent
Mechanisms of ActionNectin-4 binders
TargetsNectin-4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYunnan Baiyao Group Co LtdThe First Affiliated Hospital Of Beijing UniversityYunhe Pharmaceutical (Tianjin) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Beijing UniversityYunhe Pharmaceutical (Tianjin) Co LtdYunnan Baiyao Group Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A